Results 11 to 20 of about 1,366 (166)
Anemia sideroblástica por una variante en el gen ALAS2
Las anemias sideroblásticas (AS) son un grupo heterogéneo de patologías raras en las que se ve afectada la biosíntesis del hemo y la utilización del hierro durante la síntesis de la hemoglobina.
F. Aguirre +12 more
exaly +4 more sources
Background Congenital sideroblastic anemia (CSA) and thalassemia are both hereditary disorders of erythropoiesis, primarily affecting erythroid cells. Their typical manifestations include anemia and iron overload. In this study, we conducted clinical and
Zhi-Xiao Chen +6 more
doaj +4 more sources
A novel ALAS2 mutation causes congenital sideroblastic anemia
Kun Yang
doaj +4 more sources
CLPX and CLPP proteins are required for regulation of ALAS2
Heme synthesis consists of a series of eight enzymatic steps that result in the synthesis of porphyrin products, which in turn can be used to generate other tetrapyrrole compounds. In late-stage erythropoiesis, these precursors can be converted into its terminal product, heme.
Carter, Stashauna S.
openaire +3 more sources
X-linked macrocytic dyserythropoietic anemia in females with an ALAS2 mutation [PDF]
Macrocytic anemia with abnormal erythropoiesis is a common feature of megaloblastic anemias, congenital dyserythropoietic anemias, and myelodysplastic syndromes. Here, we characterized a family with multiple female individuals who have macrocytic anemia. The proband was noted to have dyserythropoiesis and iron overload.
Vijay G, Sankaran +11 more
openaire +5 more sources
Expression of murine 5-aminolevulinate synthase variants causes protoporphyrin IX accumulation and light-induced mammalian cell death. [PDF]
5-Aminolevulinate synthase (ALAS; EC 2.3.1.37) catalyzes the first committed step of heme biosynthesis in animals. The erythroid-specific ALAS isozyme (ALAS2) is negatively regulated by heme at the level of mitochondrial import and, in its mature form ...
Erica J Fratz +2 more
doaj +2 more sources
We report a case of severe anemia caused by complex hereditary spherocytosis (HS) and X-linked sideroblastic anemia (XLSA) with two mutations in the spectrin beta (SPTB) and 5-aminolevulinic acid synthase (ALAS2) genes. The proband was a 16-year-old male
Jianying Zhou +3 more
semanticscholar +2 more sources
ALAS2 acts as a modifier gene in patients with congenital erythropoietic porphyria
Abstract Mutations in the uroporphyrinogen III synthase (UROS) gene cause congenital erythropoietic porphyria (CEP), an autosomal-recessive inborn error of erythroid heme biosynthesis. Clinical features of CEP include dermatologic and hematologic abnormalities of variable severity. The discovery of a new type of erythroid porphyria, X-
Jordi, To-Figueras +13 more
openaire +3 more sources
Human aminolevulinate synthase structure reveals a eukaryotic-specific autoinhibitory loop regulating substrate binding and product release [PDF]
Mutation of the C-terminal extension of 5′-aminolevulinate synthase 2 (ALAS2) is the molecular cause for X-linked protoporphyria, but the underlying mechanism is unclear.
Henry J. Bailey +11 more
doaj +2 more sources
Brain tissue haemoglobin expression in saline-perfused vs non-perfused rodents
Haemoglobin beta (Hbb) and delta-aminolevulinate synthase 2 (Alas2) messenger RNA (mRNA) is mainly found in immature red blood cells, reticulocytes, and not in mature erythrocytes.
Marion Walser +5 more
doaj +3 more sources

